You are seeing this message because your Web browser does not support basic Web standards. Find out more about why this message is appearing and what you can do to make your experience on this site better.


ABOUT JAMA
Advanced Search

Welcome   | My Account | E-mail Alerts | Access Rights | Sign In


  Vol. 294 No. 16, October 26, 2005 TABLE OF CONTENTS
  JAMA
  •  Online Features
  Commentary
 This Article
 •Full text
 •PDF
 •Send to a friend
 • Save in My Folder
 •Save to citation manager
 •Permissions
 Citing Articles
 •Citation map
 •Citing articles on HighWire
 •Citing articles on Web of Science (26)
 •Contact me when this article is cited
 Related Content
 •Related letters
 •Similar articles in JAMA
 Topic Collections
 •Aging/ Geriatrics
 •Informatics/ Internet in Medicine
 •Internet
 •Medical Practice
 •Health Policy
 •Law and Medicine
 •Facial Plastic Surgery
 •Cosmetic Surgery/ Procedures
 •Alert me on articles by topic
 Social Bookmarking
  Add to CiteULike Add to Connotea Add to Del.icio.us Add to Digg Add to Reddit Add to Technorati Add to Twitter What's this?

Provision or Distribution of Growth Hormone for "Antiaging"

Clinical and Legal Issues

Thomas T. Perls, MD, MPH; Neal R. Reisman, MD, JD; S. Jay Olshansky, PhD

JAMA. 2005;294:2086-2090.

Since this article does not have an abstract, we have provided the first 150 words of the full text and any section headings.

The distribution and marketing of human growth hormone (HGH or GH) via Web sites and antiaging clinics has grown into a multimillion-dollar antiaging industry.1-4 Despite congressional hearings warning of deceptive marketing claims and the potential health and economic dangers associated with the antiaging industry,5-6 and statements issued by the National Institute on Aging7-9 and the Federal Trade Commission,10 the distribution and use of GH for antiaging is now common. For example, entering the terms "HGH" and "anti-aging" into the Google search engine generated 3 410 000 hits as of September 26, 2005, many representing Web sites and clinics marketing and selling GH.

Worldwide annual sales of GH are estimated to be $1.5 to $2 billion.4, 11 Vance12 has suggested that 30% of GH prescriptions in the United States are for indications not approved by the Food and Drug Administration . . . [Full Text of this Article]

Clinical Effects of GH

Author Affiliations: Geriatrics Section, Department of Medicine, Boston Medical Center and Boston University School of Medicine, Boston, Mass (Dr Perls); Department of Plastic Surgery, Baylor College of Medicine, and St Luke’s Episcopal Hospital, Houston, Tex (Dr Reisman); School of Public Health, University of Illinois at Chicago, Chicago, Ill (Dr Olshansky).



Add to CiteULike CiteULike   Add to Connotea Connotea   Add to Del.icio.us Del.icio.us   Add to Digg Digg   Add to Reddit Reddit   Add to Technorati Technorati   Add to Twitter Twitter     What's this?

RELATED LETTERS

Growth Hormone for "Antiaging"
Thierry Hertoghe and Suzie Schuder
JAMA. 2006;295(8):888.
EXTRACT | FULL TEXT  

Growth Hormone for "Antiaging"
Claude Dalle and Vicario Claude
JAMA. 2006;295(8):889.
EXTRACT | FULL TEXT  

Growth Hormone for "Antiaging"
Bernhard Sauter
JAMA. 2006;295(8):889.
EXTRACT | FULL TEXT  

Growth Hormone for "Antiaging"—Reply
Thomas Perls, Neal R. Reisman, and S. Jay Olshansky
JAMA. 2006;295(8):889-890.
EXTRACT | FULL TEXT  


THIS ARTICLE HAS BEEN CITED BY OTHER ARTICLES

Statement by the Growth Hormone Research Society on the GH/IGF-I Axis in Extending Health Span
Thorner
J Gerontol A Biol Sci Med Sci 2009;64A:1039-1044.
ABSTRACT | FULL TEXT  

Systematic Review: The Effects of Growth Hormone on Athletic Performance
Liu et al.
ANN INTERN MED 2008;148:747-758.
ABSTRACT | FULL TEXT  

Update in Pituitary Disease
Melmed
J. Clin. Endocrinol. Metab. 2008;93:331-338.
ABSTRACT | FULL TEXT  

Association of Total Insulin-Like Growth Factor-I, Insulin-Like Growth Factor Binding Protein-1 (IGFBP-1), and IGFBP-3 Levels with Incident Coronary Events and Ischemic Stroke
Kaplan et al.
J. Clin. Endocrinol. Metab. 2007;92:1319-1325.
ABSTRACT | FULL TEXT  

DHEA and Testosterone in the Elderly
Page et al.
NEJM 2007;356:635-637.
FULL TEXT  

Systematic Review: The Safety and Efficacy of Growth Hormone in the Healthy Elderly
Liu et al.
ANN INTERN MED 2007;146:104-115.
ABSTRACT | FULL TEXT  

Growth Hormone for "Antiaging"
Hertoghe and Schuder
JAMA 2006;295:888-888.
FULL TEXT  

Growth Hormone for "Antiaging"
Dalle and Claude
JAMA 2006;295:889-889.
FULL TEXT  

Growth Hormone for "Antiaging"
Sauter
JAMA 2006;295:889-889.
FULL TEXT  

What's new in the other general journals
Tonks
BMJ 2005;331:1045-1046.
FULL TEXT  

Drug Bust
Leslie
Sci Aging Knowl Environ 2005;2005:nf84-nf84.
ABSTRACT | FULL TEXT  





HOME | CURRENT ISSUE | PAST ISSUES | TOPIC COLLECTIONS | CME | SUBMIT | SUBSCRIBE | HELP
CONDITIONS OF USE | PRIVACY POLICY | CONTACT US | SITE MAP
 
© 2005 American Medical Association. All Rights Reserved.